Noncontiguous Stage II Grade 3 Follicular Lymphoma Active Not Recruiting Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0029309 (Noncontiguous Stage II Grade 3 Follicular Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs